A Study to Investigate if Exposure to Certain Chemical Agents Can Cause Blood Cancer
The rising number of cases of secondary acute myelogenous leukemia and related clonal cytopenias...
Read More
Hematology/Oncology
A Study into the Viability of Gilteritinib as a Drug to Treat Cancerous Cells in Adult Patients
The European Commission (EC) issued a marketing authorization for gilteritinib on October 24,...
Read More
A Phase II Study to Determine an Alternative Treatment for Blood Cancer
The relapsed and refractory acute myeloid leukemia’s optimal salvage chemotherapy regimen stays...
Read More
An Evasive Yet Curable Form of Blood Cancer
A distinctive chronic lymphoproliferative disorder is hairy cell leukemia (HCL). It is linked with...
Read More
Risk of Cancer in People with High Body Mass Index
People with high body mass index (BMI) are at a greater risk for developing cancer as indicated by...
Read More
The Link Between Autoimmune Disorders and Blood Cancer
The clonal proliferation of T cells is known as T-cell large granular lymphocyte (LGL). Anemia,...
Read More
Psychological Distress More Likely in Young Adult Cancer Survivors
MONDAY, Jan. 10, 2022 (HealthDay News) — Adolescent and young adult (AYA) cancer survivors...
Read More
Administering Tyrosine Kinase Inhibitors in Female Cancer Patients and their Gestations
Investigating the results of planned pregnancy in female patients who are diagnosed with chronic...
Read More
Recurrence of Disease after Discontinuation of Ibrutinib in Cancer Patients
After discontinuing ibrutinib, roughly 25% of patients diagnosed with chronic lymphocytic leukemia...
Read More
Correlation Between Imatinib and the Fall in Mortality Rates of Blood Cancer Patients in Two Nations
The effect of imatinib on mortality from chronic myelogenous leukemia (CML) has not been assessed...
Read More
Older Cancer Patients and Physicians’ Conflicting Views Regarding the Advantages and Disadvantages of Treatment Procedures
“Intensive” chemotherapy which bears a noteworthy amount of toxicity with a minor chance of cure...
Read More
Treating Blood Cancer with Rituximab and its Probable Substitute
Observation for the clinically silent or asymptomatic disease is needed in order to manage chronic...
Read More
Top Methods to Monitor and Manage Leukemia
A combination of clinical and laboratory monitoring is needed for the optimal utilization of...
Read More
Latest Progress in the Treatment of a Common Form of Blood Cancer
As of recently, different areas in the treatment of acute myelogenous leukemia (AML) have seen a...
Read More
RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer.
Most ovarian cancer patients are diagnosed at an advanced stage and have a high mortality rate....
Read More
Incarceration Tied to Lower Life Expectancy in Blacks
FRIDAY, Jan. 7, 2022 (HealthDay News) — Incarceration is associated with a higher mortality...
Read More
Eltrombopag Augments Immunosuppression in Severe Aplastic Anemia
THURSDAY, Jan. 6, 2022 (HealthDay News) — Among previously untreated patients with severe...
Read More
Stage Shift Tied to Decreased Population Mortality in NSCLC
WEDNESDAY, Jan. 5, 2022 (HealthDay News) — A stage shift from later- to earlier-stage...
Read More
Maternal Hormonal Contraception, CNS Tumors Not Linked in Children
TUESDAY, Jan. 4, 2022 (HealthDay News) — Maternal hormonal contraception use is not...
Read More
Major Financial Hardship Prevalent in Metastatic Colorectal Cancer
TUESDAY, Jan. 4, 2022 (HealthDay News) — More than 70 percent of patients with metastatic...
Read More